TY - JOUR
T1 - Safety and feasibility of transcranial direct current stimulation in amyotrophic lateral sclerosis–a pilot study with a single subject experimental design
AU - Madhavan, Sangeetha
AU - Sivaramakrishnan, Anjali
AU - Bond, Sam
AU - Jiang, Qin Li
N1 - Publisher Copyright:
© 2018, © 2018 Taylor & Francis.
PY - 2019/5/4
Y1 - 2019/5/4
N2 - Introduction: Transcranial direct current stimulation (tDCS) has been explored as a neuromodulatory tool to prime motor function in several neurological disorders. Studies using tDCS in amyotrophic lateral sclerosis (ALS) are limited. We investigated the safety, feasibility and effects of long-term tDCS in an individual with ALS. Methods: A 36-year-old male diagnosed with clinically definite ALS received 12 sessions each of anodal, sham, and cathodal tDCS. Outcome measures included disease progression (revised ALS functional rating scale (ALSFRS-R)), clinical measures of endurance and mobility, and corticomotor excitability. Results: No adverse events or change in disease progression were noticed during the study. Small improvement in gait speed (15% increase) was noticed with anodal tDCS only. Conclusions: This case study demonstrates the safety and feasibility of long-term facilitatory and inhibitory tDCS on a single participant with ALS. This study serves as a guideline for implementing tDCS in future ALS trials.
AB - Introduction: Transcranial direct current stimulation (tDCS) has been explored as a neuromodulatory tool to prime motor function in several neurological disorders. Studies using tDCS in amyotrophic lateral sclerosis (ALS) are limited. We investigated the safety, feasibility and effects of long-term tDCS in an individual with ALS. Methods: A 36-year-old male diagnosed with clinically definite ALS received 12 sessions each of anodal, sham, and cathodal tDCS. Outcome measures included disease progression (revised ALS functional rating scale (ALSFRS-R)), clinical measures of endurance and mobility, and corticomotor excitability. Results: No adverse events or change in disease progression were noticed during the study. Small improvement in gait speed (15% increase) was noticed with anodal tDCS only. Conclusions: This case study demonstrates the safety and feasibility of long-term facilitatory and inhibitory tDCS on a single participant with ALS. This study serves as a guideline for implementing tDCS in future ALS trials.
KW - Amyotrophic lateral sclerosis
KW - cortical excitability
KW - neurodegenerative disease
KW - transcranial direct current stimulation
KW - transcranial magnetic stimulation
UR - http://www.scopus.com/inward/record.url?scp=85042912740&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042912740&partnerID=8YFLogxK
U2 - 10.1080/09593985.2018.1443536
DO - 10.1080/09593985.2018.1443536
M3 - Article
C2 - 29488820
AN - SCOPUS:85042912740
SN - 0959-3985
VL - 35
SP - 458
EP - 463
JO - Physiotherapy Theory and Practice
JF - Physiotherapy Theory and Practice
IS - 5
ER -